Helmy Eltoukhy
PhD, Stanford University. Chief Executive Officer of the Guardant Health precision oncology company, and provider of the GuardantINFORM real-world clinical-genomic platform. Guardant is sponsor of the GRECO-breast cancer study.
Test announcement
Announcement here about some event or update. Or maybe link to promoted article.
More reads
Skepticism Warranted Regarding New Study Suggesting Link Between Chemical Exposures And IQ Loss
Earlier today, Dr. Leonardo Trasande and colleagues from New
York University (NYU) published
yet another in a series of economic studies which they interpret to
indicate that low level general…
Important Milestone Reached On Road To A Redefined Kilogram
WASHINGTON, D.C., June 21, 2016 - In a secure vault in the suburbs of Paris, an egg-sized cylinder of metal sits in a climate-controlled room under three glass bell jars. It is the mass against which…
Sepsis, Chronic Ventilation Usage, Blood Clotting: Risk Factors For Coronavirus Death Identified
A new paper has identified the risk factors for death from COVID-19, also called coronavirus and Wuhan flu, and they are much like any other flu; being older and having pre-existing conditions are…